kitatipithitamak mithwayawin: Evaluating impacts of an existing Indigenous-led project on COVID-19, which includes past work on risk communication, present work on digital health, and a future international gathering for impacted Indigenous communities around the world.

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:9 publications

Grant number: 174975

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $158,000
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Stephane M Mclachlan
  • Research Location

    Canada
  • Lead Research Institution

    University of Manitoba
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Approaches to public health interventions

  • Special Interest Tags

    Digital Health

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Minority communities unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19 has swept around the globe and has already resulted in over 1.5 million deaths. In the past, Indigenous people were devastated by pandemics including smallpox, Spanish flu and H1N1 and cases of COVID-19 are now rising quickly in many communities. This proposal builds on the activities of our existing project that focuses on COVID-19 and Indigenous people. Named kitatipithitamak mithwayawin, Cree for control or sovereignty over wellbeing, its goal is to document the past, present and future impacts of pandemics. And to support Indigenous communities as they respond to COVID-19. This proposal similarly aims to extend its scope and impact in three ways. i)Past work: Evaluate impacts of our existing activities focusing on Indigenous risk communication. These reflect videos, webinars, workshops, and infographics that are shared on our project website < http://covid19indigenous.ca/> and Facebook page < https://www.facebook.com/covid19indigenous/> ii)Present work: Expand a new digital health initiative that will use web and mobile apps to provide health directors with real-time health data for local decision-making. We will expand these efforts to include any First Nations, Metis, and Inuit communities in Canada wanting to participate. We will also evaluate the benefits and any shortcomings of these apps in local decision-making regarding COVID-19 and wellbeing as a whole. iii)Future work: Hold an international (virtual) conference in May 2021 that brings Indigenous communities and scholars from around the world to share their experiences with COVID-19 and to learn from one another. This will ideally result in an Indigenous-led network of support that helps communities respond to pandemics in the future. The impacts of the conference and network will also be evaluated. In closing, this proposal expands our existing Indigenous-led project on COVID-19 and does so in ways that serve the interests of any and all Indigenous communities regardless of location.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Poly(Sarcosine) Surface Modification Imparts Stealth-Like Properties to Liposomes.

Bioinspired Molecular Factories with Architecture and In Vivo Functionalities as Cell Mimics.

Controlled Tyrosine Kinase Inhibitor Delivery to Liver Cancer Cells by Gate-Capped Mesoporous Silica Nanoparticles.

Optimization-by-design of hepatotropic lipid nanoparticles targeting the sodium-taurocholate cotransporting polypeptide.

Rapid optimization of liposome characteristics using a combined microfluidics and design-of-experiment approach.

Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery.

Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo.

Zebrafish as a preclinical in vivo screening model for nanomedicines.

Translating nanomedicines: Thinking beyond materials? A young investigator's reply to 'The Novelty Bubble'.